Pubblicazioni

Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC PatientsâA Retrospective Observational Study

2023 - CANCERS

Siringo, Marco; Gentile, Gabriella; Caponnetto, Salvatore; Sperduti, Isabella; Santini, Daniele; Cortesi, Enrico; Gelibter, ALAIN JONATHAN

Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review

2022 - CANCERS

Gallina, F. T.; Bertolaccini, L.; Forcella, D.; Mohamed, S.; Ceddia, S.; Melis, E.; Fusco, F.; Bardoni, C.; Marinelli, D.; Buglioni, S.; Visca, P.; Cappuzzo, F.; Spaggiari, L.; Facciolo, F.

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

2022 - CANCERS

Leone, Alvaro; Muscarella, Lucia Anna; Graziano, Paolo; Tornese, Andrea; Grillo, Lucia Rosalba; Di Lorenzo, Angela; Bronzini, Monica; Scarpino, Stefania; Sparaneo, Angelo; Rossi, Giulio

Pubblicazioni

Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC PatientsâA Retrospective Observational Study

Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC PatientsâA Retrospective Observational Study